# Chirag Patel

> Chirag Patel is the co-founder, President and Co-Chief Executive Officer of Amneal Pharmaceuticals. He and his brother Chintu established the business in 2002; Chirag joined full-time in 2005 and returned to executive leadership in August 2019. His work outside Amneal includes investments in other companies, the Niswarth International Foundation with his wife Priti, and scholarships linking H.A. College of Commerce with New Jersey City University.

- **Role:** President and Co-Chief Executive Officer at Amneal Pharmaceuticals
- **Organizations:** Amneal Pharmaceuticals, Niswarth International Foundation, NextGen Technologies, Veriprise Wireless, Asana BioSciences, Kashiv BioSciences, Prolong Pharmaceuticals, Liberty Science Center, Association for Accessible Medicines, International Generic and Biosimilar Medicines Association
- **Education:** Bachelor’s degree in Commerce, H.A. College of Commerce, Bachelor’s degree in Business Administration, New Jersey City University, Honorary Doctor of Humane Letters, New Jersey City University
- **Known for:** Shared the 2011 EY National Entrepreneur Of The Year Life Sciences Award with Chintu Patel., Supported tuition scholarships from H.A. College of Commerce to New Jersey City University., Received an honorary Doctor of Humane Letters from New Jersey City University.

## Career timeline

- **1987** — His family immigrated from India to the United States.
- **1989** — Graduating class at New Jersey City University, as identified in its presidential inauguration speech.
- **Before 2005** — Co-founded technology companies NextGen Technologies and Veriprise Wireless.
- **2002** — Co-founded Amneal with his brother Chintu; the company began in Paterson, New Jersey.
- **2005** — Committed to Amneal full-time.
- **2011** — Chirag and Chintu won the EY National Entrepreneur Of The Year Life Sciences Award.
- **2013** — Established the Niswarth International Foundation with his wife Priti.
- **2015** — Visited H.A. College of Commerce on December 28 to finalize the NJCU scholarship agreement.
- **2018** — Amneal combined with Impax; Chirag became co-chairman of the combined company.
- **2019** — Returned as President and Co-Chief Executive Officer on August 5.
- **2022** — Served as board chair of the Association for Accessible Medicines.
- **2026** — Amneal completed the acquisition of Kashiv BioSciences on August 10.

## Achievements

- Shared the 2011 EY National Entrepreneur Of The Year Life Sciences Award with Chintu Patel.
- Supported tuition scholarships from H.A. College of Commerce to New Jersey City University.
- Received an honorary Doctor of Humane Letters from New Jersey City University.
- Selected for NJCU’s 2014 Alumnus of Distinction Award.
- Co-founded Amneal and returned to lead it as a public company in 2019.

## Latest updates

- **2026-10** — Amneal announced that third-quarter results would be reported on November 3, 2026.
- **2026-08** — Amneal completed its Kashiv BioSciences acquisition on August 10.
- **2026-07** — Amneal reported Q2 net revenue of $796 million, up 10% year over year, and GAAP net income of $58 million.
- **2026-07** — Amneal announced selection of its planned approximately 75,000-square-foot Brookhaven manufacturing facility for the FDA PreCheck Pilot Program.

## Links

- Website: https://amneal.com
- LinkedIn: https://www.linkedin.com/in/chirag-patel-amneal

---

Profile page: https://yespress.io/chirag-patel
Published by YesPress — https://yespress.io
Last updated: 2026-10-24